Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents
Authors
Keywords
Schizophrenia, Animal model, Muscarinic receptor, Metabotropic glutamate receptor
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 10, Pages 2897-2913
Publisher
Springer Nature America, Inc
Online
2018-07-27
DOI
10.1007/s00213-018-4980-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use
- (2017) Maren Carbon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Neurochemical and behavioral studies on the 5-HT 1A -dependent antipsychotic action of the mGlu 4 receptor agonist LSP4-2022
- (2017) Monika Woźniak et al. NEUROPHARMACOLOGY
- Involvement of GABABReceptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4Receptor, LSP4-2022
- (2016) Monika Woźniak et al. Current Neuropharmacology
- Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia
- (2016) Qi-Jing Bo et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment
- (2016) Joanna M. Wierońska et al. PHARMACOLOGY & THERAPEUTICS
- Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy study
- (2016) Gagan Fervaha et al. PSYCHOPHARMACOLOGY
- Presynaptic muscarinic acetylcholine autoreceptors (M1, M2 and M4 subtypes), adenosine receptors (A1 and A2A) and tropomyosin-related kinase B receptor (TrkB) modulate the developmental synapse elimination process at the neuromuscular junction
- (2016) Laura Nadal et al. Molecular Brain
- Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
- (2016) Carolina Muguruza et al. Frontiers in Pharmacology
- Metabotropic glutamate receptors as drug targets: what's new?
- (2015) Ferdinando Nicoletti et al. CURRENT OPINION IN PHARMACOLOGY
- Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia
- (2015) Gagan Fervaha et al. SCHIZOPHRENIA RESEARCH
- Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
- (2015) Amr Ellaithy et al. TRENDS IN NEUROSCIENCES
- M4 mAChR-Mediated Modulation of Glutamatergic Transmission at Corticostriatal Synapses
- (2014) Tristano Pancani et al. ACS Chemical Neuroscience
- Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
- (2014) Michael Bubser et al. ACS Chemical Neuroscience
- Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100
- (2014) Nellie E Byun et al. NEUROPSYCHOPHARMACOLOGY
- Effects of Selective Activation of M1 and M4 Muscarinic Receptors on Object Recognition Memory Performance in Rats
- (2014) Claire R. Galloway et al. PHARMACOLOGY
- The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent
- (2013) Joanna M. Wierońska et al. BEHAVIOURAL BRAIN RESEARCH
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Kami-ondam-tang, a traditional herbal prescription, attenuates the prepulse inhibition deficits and cognitive impairments induced by MK-801 in mice
- (2013) Hee Kyong Oh et al. JOURNAL OF ETHNOPHARMACOLOGY
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
- (2013) E M P Poels et al. MOLECULAR PSYCHIATRY
- Synaptic muscarinic response types in hippocampal CA1 interneurons depend on different levels of presynaptic activity and different muscarinic receptor subtypes
- (2013) L. Andrew Bell et al. NEUROPHARMACOLOGY
- Qualification of LSP1-2111 as a Brain Penetrant Group III Metabotropic Glutamate Receptor Orthosteric Agonist
- (2013) Manuel Cajina et al. ACS Medicinal Chemistry Letters
- A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential
- (2012) Cyril Goudet et al. FASEB JOURNAL
- Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons
- (2012) Mahomi Kuroiwa et al. NEUROPHARMACOLOGY
- The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: Iodine-123-iodobenzamide single photon emission computed tomography study
- (2012) Iluminada Corripio et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- An allosteric enhancer of M4 muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine
- (2012) Ditte Dencker et al. PSYCHOPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
- (2011) Joanna M. Wierońska et al. PSYCHOPHARMACOLOGY
- Impact of isoflurane anesthesia on D2 receptor occupancy by [18F]fallypride measured by microPET with a modified Logan plot
- (2011) Mohammed N. Tantawy et al. SYNAPSE
- Impact of species variability and ‘probe-dependence’ on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor
- (2010) S Suratman et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors
- (2010) J. Jeon et al. JOURNAL OF NEUROSCIENCE
- Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited
- (2010) A. Heinz et al. SCHIZOPHRENIA BULLETIN
- Physiology and Pharmacology of Striatal Neurons
- (2009) Anatol C. Kreitzer Annual Review of Neuroscience
- [18F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot
- (2009) Mohammed N. Tantawy et al. NUCLEAR MEDICINE AND BIOLOGY
- Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia
- (2009) Dawn I. Velligan et al. PSYCHIATRY RESEARCH
- Disability and treatment of specific mental and physical disorders across the world
- (2008) Johan Ormel et al. BRITISH JOURNAL OF PSYCHIATRY
- Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats
- (2008) A. E. Brady et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
- (2008) P. Jeffrey Conn et al. NATURE REVIEWS DRUG DISCOVERY
- The putative antipsychotic alstonine reverses social interaction withdrawal in mice
- (2008) Viviane de Moura Linck et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
- (2008) P. Jeffrey Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now